Vial Breakage Leads to Recall of 49 Lots of Sodium Bicarbonate
Exela has received five reports of flying glass injuring skin, eye and/or other parts. The recall includes both Exela and Civica brands.
Exela Pharma Sciences is recalling 49 lots of sodium bicarbonate injection. The product is used for treatment of metabolic acidosis, which is the buildup of acid in the body because of kidney or liver failure. It is packaged in a 50 mL glass vial, 20 vials per carton. Exela has received five reports of flying glass injuring skin, eye and/or other parts. There have been no reports of sterility failures.
The recall includes both Exela and Civica brands. The products of both manufacturers have a yellow flip-top safety cap on the 50 mL vial. The product was distributed between Dec. 16, 2021, and Aug. 10, 2022.
The Exela carton has an NDC number of 51754-5001-5 and a vial NDC of 51754-5001-1. The carton has a purple stripe containing concentration information and the manufacturer name in the lower right-hand corner. The Civica carton has an NDC number of 72572-740-20 and a vial NDC of 72572-740-1. The carton has green stripe containing concentration information and the manufacturer name in the lower right-hand corner.
Lot numbers and expiration dates can be found here.
Exela does not expect this recall to impact drug supply.
Iowa Expands PBM Legislation to Address Concerns of Independent Pharmacies
May 16th 2025A new law in Iowa, if signed by the governor, will mandate 100% pass-through of rebates, increased financial transparency, and a minimal payment for pharmacies. Critics say it will be the most costly mandate in the state’s history.
Read More
Is Arkansas’ New PBM Law the Right Path Forward for Reform? No One Knows Yet
May 9th 2025It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are unsure about the impact of Arkansas’ law banning PBMs from owning pharmacies.
Read More
